Evidence map›Paper›PMID 38666479›Full record

ArticleJournal of cutaneous pathology2024

Subungual melanoma with cartilaginous differentiation: Molecular insights.

Umayr Shaikh, Payal Shah, Victoria Jones, Alvaro J Ramos-Rodriguez, Aravindhan Sriharan, Eric Loo, Wahab A Khan, Brian Simmons, Jeffrey M Cloutier

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of cutaneous pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Umayr ShaikhSchool of Medicine, Georgetown University, Washington, DC, USA.
Payal ShahDepartment of Dermatology, Dartmouth Health, Lebanon, New Hampshire, USA.
Victoria JonesDepartment of Pathology and Laboratory Medicine, One Medical Center Drive, Dartmouth Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Alvaro J Ramos-RodriguezDepartment of Pathology and Laboratory Medicine, One Medical Center Drive, Dartmouth Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.ORCID https://orcid.org/0009-0006-5954-2885
Aravindhan SriharanDepartment of Pathology and Laboratory Medicine, One Medical Center Drive, Dartmouth Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Eric LooDepartment of Pathology and Laboratory Medicine, One Medical Center Drive, Dartmouth Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Wahab A KhanDepartment of Pathology and Laboratory Medicine, One Medical Center Drive, Dartmouth Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Brian SimmonsDepartment of Dermatology, Dartmouth Health, Lebanon, New Hampshire, USA.
Jeffrey M CloutierDepartment of Pathology and Laboratory Medicine, One Medical Center Drive, Dartmouth Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.ORCID https://orcid.org/0000-0002-8630-8609
Dartmouth–Hitchcock Medical Center · USDartmouth Institute for Health Policy and Clinical Practice · USGeorgetown University · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
NCI NIH HHS 5P30 CA023108-37NCI NIH HHS P30 CA023108
6 · The paper itself

Abstract

Melanoma's rare capacity to undergo heterologous differentiation can create significant diagnostic challenges. The molecular mechanisms underlying this phenomenon are not well understood. We present an unusual case of subungual melanoma exhibiting extensive cartilaginous differentiation and provide insights into its molecular and cytogenomic features. Histopathologically, the tumor was predominantly composed of nodules of malignant cartilage in association with a smaller population of nested epithelioid to rhabdoid cells. Immunohistochemically, the tumor cells in both components were positive for S100, SOX10, and PRAME, and were negative for Melan-A and HMB-45. Molecular analysis by whole exome DNA sequence did not detect any pathogenic variants in genes commonly implicated in melanoma. Additional analysis by SNP chromosomal microarray revealed a complex genome characterized by numerous chromosomal losses and gains, including a homozygous deletion of the CDKN2A locus and a heterozygous deletion of the locus containing EXT2, a tumor suppressor implicated in hereditary multiple osteochondromas and secondary chondrosarcomas. This case underscores the importance of recognizing cartilaginous differentiation as a rare manifestation of melanoma, particularly at subungual sites, and suggests that at least some of these melanomas may be driven by non-canonical molecular pathways.

Indexed as

MelanomaNail DiseasesSkin NeoplasmsAntigens, NeoplasmCartilageCell DifferentiationCyclin-Dependent Kinase Inhibitor p16FemaleHumansMaleS100 ProteinsSOXE Transcription FactorsAntigens, NeoplasmCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16PRAME protein, humanS100 ProteinsSOX10 protein, humanSOXE Transcription Factorscartilaginous differentiationchondrosarcomaheterologous differentiationmelanomasubungual

Identifiers

PMID38666479
PMCPMC12879971
OpenAlexW4395675253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.